DRIVIN G ROWTH - Dr. Reddy's

162
consolidated cash flow statement | YEAR ENDED MARCH 31
(All amounts in Indian Rupees thousands, except share data)
Cash flows from operating activities
Profit before taxation
Adjustments:
4,612,856
Depreciation 522,717
Amortisation of long-term deposits 22,750
Income from redemption of mutual fund units (19,420)
Unrealised foreign exchange gain (118,698)
Deferred revenue expenditure written-off 931,354
Amortisation of marketing development expenditure 11,748
Provision for decline in long-term investments 150,656
Long term investments written-off 8,215
Interest income (103,786)
Dividend income (35)
Interest expense 114,937
Loss on sale of fixed assets (net) 27.086
Preliminary expenses written-off 500
Operating cash flows before working capital changes 6,160,880
(Increase) / decrease in sundry debtors (1,052,809)
(Increase) / decrease in inventories (249,251)
(Increase) / decrease in loans and advances (185,197)
Increase / (decrease) in current liabilities and provisions 474,840
Cash generated from operations 5,148,463
Income taxes paid (456,970)
Net cash provided by operating activities
Cash flows from investing activities
4,691,493
Purchase of fixed assets (1,567,796)
Proceeds from sale of fixed assets 44,394
Purchase of investments (2,363,549)
Sale of investments 2,363,680
Advances given to joint ventures (39,610)
Dividend received 35
Interest received 94,941
Net cash used in investing acivities (1,467,905)
As per our report attached. For DR. REDDY’S LABORATORIES LIMITED
For BHARAT S RAUT & CO. DR. K ANJI REDDY Chairman
Chartered Accountants G V PRASAD Executive Vice Chairman & CEO
K SATISH REDDY Managing Director & COO
PRADIP KANAKIA DR. OMKAR GOSWAMI Director
Partner V S VASUDEVAN Chief Financial Officer
SANTOSH KUMAR NAIR Company Secretary
For A RAMACHANDRA RAO & CO.
Chartered Accountants
A RAMACHANDRA RAO
Partner
Hyderabad
June 4, 2002
CONSOLIDATED FINANCIALS | FINANCIALS | ANNUAL REPORT 2001-2002
2002